Janney Montgomery Scott
MCRB icon

Janney Montgomery Scott’s Seres Therapeutics MCRB Stock Holding History

Janney Montgomery Scott’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$14K – 2781
2025
Q1 		$14K Sell
1,000
-1,425
-59% -$22.3K ﹤0.01% 2653
2024
Q4 		$40K Sell
2,425
-1,030
-30% -$16.7K ﹤0.01% 2659
2024
Q3 		$65K Sell
3,455
-300
-8% -$6.09K ﹤0.01% 2607
2024
Q2 		$54K Hold
3,755
– – ﹤0.01% 2559
2024
Q1 		$58K Hold
3,755
– – ﹤0.01% 2675
2023
Q4 		$105K Sell
3,755
-489
-12% -$12.8K ﹤0.01% 2546
2023
Q3 		$202K Sell
4,244
-270
-6% -$20.6K ﹤0.01% 2376
2023
Q2 		$432K Sell
4,514
-600
-12% -$65.3K ﹤0.01% 1986
2023
Q1 		$580K Buy
5,114
+266
+5% +$28.8K ﹤0.01% 1630
2022
Q4 		$543K Buy
4,848
+608
+14% +$81.5K ﹤0.01% 1713
2022
Q3 		$544K Buy
4,240
+100
+2% +$10.2K ﹤0.01% 1649
2022
Q2 		$264K Buy
4,140
+870
+27% +$74.9K ﹤0.01% 1987
2022
Q1 		$466K Buy
3,270
+1,105
+51% +$170K ﹤0.01% 1659
2021
Q4 		$361K Buy
2,165
+830
+62% +$132K ﹤0.01% 1901
2021
Q3 		$186K Buy
+1,335
New +$261K ﹤0.01% 2178

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Janney Montgomery Scott's MCRB Position: Q2 2025 in Review

Janney Montgomery Scott sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 1,000 shares — an estimated $14K sold.

Janney Montgomery Scott first reported a position in MCRB in Q3 2021 and held it in 15 quarters. The position peaked at $580K in Q1 2023. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Janney Montgomery Scott reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 1,000 Seres Therapeutics shares in Q2 2025, an estimated $14K.
  • Janney Montgomery Scott first reported a position in Seres Therapeutics in Q3 2021 and held it in 15 quarters.
  • Janney Montgomery Scott's Seres Therapeutics position peaked at $580K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Janney Montgomery Scott's 13F filing for Q2 2025, filed 17 Jul 2025.